Join Picard Medical/SynCardia for a virtual business update featuring key opinion leaders (KOLs) Amy Fiedler, MD (Associate Professor of Surgery, Surgical Director of Heart Transplantation and Mechanical Circulatory Support, UCSF) and Zain Khalpey, MD, PhD, FACS (Chief Medical Artificial Intelligence Officer, Network Director for the Artificial Heart Program, HonorHealth, Phoenix) who will join company management to discuss the SynCardia Total Artificial Heart (STAH), designed to completely replace a diseased human heart for bridge-to-transplant purposes and therefore an essential option for transplant centers to have available to their patients. The Company’s next-generation total artificial heart, the Emperor, which is fully implantable and driverless, will also be discussed.

Management will review Picard Medical’s fiscal year and fourth quarter 2025 results, and provide a business update covering operational progress, commercial activity, and strategic priorities. Presentations will be delivered by Patrick NJ Schnegelsberg, Chief Executive Officer; Matthew Schuster, Chief Operating Officer; and Bernard Skaggs, Chief Financial Officer. The event will include perspectives from KOLs mentioned above on the STAH as well as the artificial heart landscape, a personal testimonial reflecting a patient’s clinical experience with SynCardia’s total artificial heart.

A live question and answer session will follow the formal presentations.